There was a borderline significant trend towards a higher proportion of patients receiving oral corticosteroid therapy in the COVID-19 group compared to the negative group—35 vs. 30 patients (χ 2 = 3.2, p = 0.051).
← all excerpts
Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study.
1
—
—